PTPN22 and renal cell carcinoma: Results demonstrated that PTPN22 knockdown significantly increased tyrosine phosphorylation levels of CBL in RCC cells (Figure 3E), while subsequent PTPN22 overexpression significantly reversed phosphorylation levels (Figure 3F).